Microbot Medical Boosts C-Suite Compensation, Awards CEO Special Bonus

summarizeSummary

Microbot Medical Inc. announced increased salaries and bonus potential for its CTO, CFO, and CMO, alongside a $140,000 special bonus for its CEO, signaling a focus on executive retention and motivation.

check_boxKey Events

• CTO Compensation Increased

  Simon Sharon, Chief Technology Officer, received an increase in annual base salary to NIS 1,008,000 and an increase in maximum annual bonus potential to 50% of base salary, effective for the 2026 fiscal year.

• CFO Compensation Increased

  Rachel Vaknin, Chief Financial Officer, received an increase in annual base salary to NIS 756,000 and an increase in maximum annual bonus potential to 50% of base salary, effective for the 2026 fiscal year.

• CMO Bonus Potential Increased

  Dr. Juan Diaz-Cartelle, Chief Medical Officer, had his maximum annual bonus potential increased to 50% of base salary, effective for the 2026 fiscal year.

• CEO Awarded Special Bonus

  Harel Gadot, Chief Executive Officer, President, and Chairman, was authorized to receive a special bonus of approximately $140,000.

auto_awesomeAnalysis

This filing details significant compensation adjustments for Microbot Medical's key executives, including increased base salaries for the CTO and CFO, higher maximum annual bonuses for the CTO, CFO, and CMO, and a special bonus for the CEO. These changes, effective for the 2026 fiscal year, signal the company's commitment to retaining and incentivizing its leadership team. While the direct financial impact of the CEO's bonus is modest relative to the company's market capitalization, the broad-based adjustments across the C-suite suggest confidence in the executive team's ongoing contributions and future performance.